Structural and functional basis for p38-MK2 activated Rsk signalling in Toll-Like receptor-stimulated dendritic cells

Rossana Zaru, Alexander J. Edgar, André Hanauer, Colin Watts (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    10 Citations (Scopus)
    114 Downloads (Pure)

    Abstract

    Rsk kinases play important roles in several cellular processes such as proliferation, metabolism and migration. Until recently Rsk activation was thought to be exclusively initiated by Erk1/2 but in dendritic cells (DC) Rsk is also activated by p38 MAP kinase via its downstream substrates, MK2/3. How and why this non-canonical configuration of the MAP kinase pathway is adopted by these key immune cells is not known. We demonstrate that Erk1/2-activated C-terminal kinase domain of Rsk is dispensable for p38-MK2/3 activation and show that, compared with fibroblasts, a greater fraction of p38 and MK2/3 is located in the cytosol of DC prior to stimulation, suggesting a partial explanation for the operation of the non-canonical pathway of Rsk activation in these cells. p38/MK2/3-activated Rsk phosphorylated downstream targets and is physiologically important because in plasmacytoid DC (pDC) stimulated with TLR7 agonists, Erk1/2 activation is very weak relative to p38. As a result Rsk activation is entirely p38-dependent. We show that this unusual configuration of MAP kinase signalling contributes substantially to production of type I interferons, a hallmark of pDC activation.
    Original languageEnglish
    Pages (from-to)132-140
    Number of pages9
    JournalMolecular and Cellular Biology
    Volume35
    Issue number1
    Early online date20 Oct 2014
    DOIs
    Publication statusPublished - Jan 2015

    Fingerprint Dive into the research topics of 'Structural and functional basis for p38-MK2 activated Rsk signalling in Toll-Like receptor-stimulated dendritic cells'. Together they form a unique fingerprint.

  • Profiles

    No photo of Colin Watts

    Cite this